Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bespoke Extracts (BSPK) Cash & Equivalents (2017 - 2025)

Bespoke Extracts (BSPK) has disclosed Cash & Equivalents for 9 consecutive years, with $16743.0 as the latest value for Q3 2025.

  • Quarterly Cash & Equivalents fell 21.93% to $16743.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $16743.0 through Sep 2025, down 21.93% year-over-year, with the annual reading at $60305.0 for FY2024, 812.74% up from the prior year.
  • Cash & Equivalents hit $16743.0 in Q3 2025 for Bespoke Extracts, up from $1363.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $501560.0 in Q1 2021 to a low of $1363.0 in Q2 2025.
  • Historically, Cash & Equivalents has averaged $52151.0 across 5 years, with a median of $19094.0 in 2024.
  • Biggest YoY gain for Cash & Equivalents was 27522.92% in 2021; the steepest drop was 97.56% in 2021.
  • Year by year, Cash & Equivalents stood at $6295.0 in 2021, then soared by 288.13% to $24433.0 in 2022, then tumbled by 72.96% to $6607.0 in 2023, then surged by 812.74% to $60305.0 in 2024, then crashed by 72.24% to $16743.0 in 2025.
  • Business Quant data shows Cash & Equivalents for BSPK at $16743.0 in Q3 2025, $1363.0 in Q2 2025, and $30365.0 in Q1 2025.